{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:17:46Z","timestamp":1785770266824,"version":"3.56.0"},"reference-count":81,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/ http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Inflammatory bowel disease (IBD) is commonly accompanied by psychological distress, which may worsen disease activity through gut-brain axis mechanisms. Psychological interventions including cognitive behavioral therapy (CBT) seem to reduce distress and inflammation in IBD. However, accessibility to psychological care remains limited. COMPASS-IBD, a digital CBT intervention tailored to IBD, aims to address these gaps.<\/jats:p>\n                    <jats:p>This nested exploratory, real-world study (NCT05330299) assessed the effectiveness of COMPASS-IBD in reducing inflammation, disease activity, and health care use in IBD patients. In addition, it examined relationships between changes in psychological distress and disease indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Adults with IBD experiencing psychological distress were recruited from a large gastroenterology service, and enrolled in COMPASS-IBD. Disease-related primary outcomes were faecal calprotectin (FCP), C-reactive protein (CRP), and self-reported disease activity (SRDA). Secondary outcomes included other inflammatory biomarkers (neutrophils, monocytes, lymphocytes, white blood cells (WBC), ferritin, flare frequency, and health care usage. The Patient Health Questionnaire-Anxiety and Depression Scale (PHQ-ADS) measured distress. Mixed-effects models evaluated outcomes at baseline, 12 weeks, and 6 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Sixty-five participants were included. There were significant reductions in CRP (\n                      <jats:italic toggle=\"yes\">d<\/jats:italic>\n                      range: \u22120.47 to \u22120.53,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.01), but not FCP (\n                      <jats:italic toggle=\"yes\">d<\/jats:italic>\n                      range: \u22120.38 to \u22120.44,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.10) or SRDA (\n                      <jats:italic toggle=\"yes\">d<\/jats:italic>\n                      =\u22120.28,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.08). Significant improvements were observed in WBC and neutrophil counts (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.05), flare frequency (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.01), and psychological distress (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.001). Some types of health care usage were reduced (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.05). Associations between distress and primary outcomes were nonsignificant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This pilot suggests COMPASS-IBD may reduce inflammation levels, health care use, and psychological distress. However, analyses were underpowered. Larger randomized trials are needed to confirm findings, establish cost-effectiveness, and explore underlying gut-brain mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/psy.0000000000001457","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T13:00:31Z","timestamp":1766408431000},"page":"274-286","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A Pilot Study of the Real-World Impact of Digital Cognitive Behavioral Therapy for Inflammatory Bowel Disease (COMPASS-IBD) on Inflammation, Disease Activity, and Healthcare Use"],"prefix":"10.1097","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1088-1396","authenticated-orcid":false,"given":"Natasha","family":"Seaton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2221-6684","authenticated-orcid":false,"given":"Sophie","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7868-2804","authenticated-orcid":false,"given":"Annie S. K.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2715-0184","authenticated-orcid":false,"given":"Tsz Wai","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8690-6839","authenticated-orcid":false,"given":"Valeria","family":"Mondelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0672-2621","authenticated-orcid":false,"given":"Joanna L.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2927-3446","authenticated-orcid":false,"given":"Rona","family":"Moss-Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"R1-20260402","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/01939459251314941","article-title":"Sleep deficiency and fatigue in adults with inflammatory bowel disease: a systematic review","volume":"47","author":"Conley","year":"2025","journal-title":"West J Nurs Res"},{"key":"R2-20260402","first-page":"360","article-title":"Prevalence and factors associated with fecal urgency among patients with ulcerative colitis and Crohn\u2019s disease in the study of a prospective adult research cohort with inflammatory bowel disease","volume":"3","author":"Dawwas","year":"2021","journal-title":"Crohn's & Colitis"},{"key":"R4-20260402","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.gtc.2012.06.006","article-title":"Diarrhea in chronic inflammatory bowel diseases","volume":"41","author":"Wenzl","year":"2012","journal-title":"Gastroenterol Clin North Am"},{"issue":"Suppl 3","key":"R5-20260402","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"R6-20260402","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/gastro\/gou087","article-title":"Optimizing the use of biological therapy in patients with inflammatory bowel disease","volume":"3","author":"Moss","year":"2015","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"R7-20260402","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/ibd\/izz001","article-title":"Real-world pattern of biologic use in patients with inflammatory bowel disease: treatment persistence, switching, and importance of concurrent immunosuppressive therapy","volume":"25","author":"Chen","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"R8-20260402","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","article-title":"Epidemiology and natural history of inflammatory bowel diseases","volume":"140","author":"Cosnes","year":"2011","journal-title":"Gastroenterology"},{"key":"R9-20260402","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/ecco-jcc\/jjac156","article-title":"Mortality in Patients with Inflammatory Bowel Disease: Results from 30 Years of Follow-up in a Norwegian Inception Cohort (the IBSEN study)","volume":"17","author":"Follin-Arbelet","year":"2022","journal-title":"J Crohn's Colitis"},{"key":"R10-20260402","first-page":"CD008794","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview","volume":"2011","author":"Singh","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R11-20260402","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"R12-20260402","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/ajg.2012.218","article-title":"Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT\u2122 registry","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Off J Am College Gastroenterol ACG"},{"key":"R13-20260402","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cgh.2009.11.024","article-title":"Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease","volume":"8","author":"Long","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R14-20260402","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/phar.2472","article-title":"Risk of venous thromboembolism associated with tofacitinib and baricitinib: a systematic review and indirect meta-analysis","volume":"40","author":"Gim\u00e9nez Poder\u00f3s","year":"2020","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"R15-20260402","doi-asserted-by":"crossref","first-page":"e0185500","DOI":"10.1371\/journal.pone.0185500","article-title":"A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease","volume":"12","author":"Pillai","year":"2017","journal-title":"PLoS ONE"},{"key":"R16-20260402","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S2468-1253(23)00003-1","article-title":"The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission","volume":"8","author":"Burisch","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R17-20260402","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S2468-1253(21)00014-5","article-title":"Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"6","author":"Barberio","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R19-20260402","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.gastro.2022.03.014","article-title":"Relative contribution of disease activity and psychological health to prognosis of inflammatory bowel disease during 6.5 years of longitudinal follow-up","volume":"163","author":"Fairbrass","year":"2022","journal-title":"Gastroenterology"},{"key":"R20-20260402","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/ibd\/izaa030","article-title":"Mental health costs of inflammatory bowel diseases","volume":"27","author":"Szigethy","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"R21-20260402","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.genhosppsych.2017.09.007","article-title":"Screening for psychological distress using the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS): Initial validation of structural validity in dialysis patients","volume":"50","author":"Chilcot","year":"2018","journal-title":"Gen Hosp Psychiatry"},{"key":"R22-20260402","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.genhosppsych.2024.03.004","article-title":"Psychometric validation of the 15-item Patient Health Questionnaire-Anxiety and Depression Scale (PHQ-ADS) to assess psychological distress in breast cancer survivors","volume":"88","author":"Ibrahimi","year":"2024","journal-title":"Gen Hosp Psychiatry"},{"key":"R23-20260402","doi-asserted-by":"crossref","first-page":"104910","DOI":"10.1016\/j.ebiom.2023.104910","article-title":"Do interventions for mood improve inflammatory biomarkers in inflammatory bowel disease?: A systematic review and meta-analysis","volume":"100","author":"Seaton","year":"2024","journal-title":"EBioMedicine"},{"key":"R24-20260402","first-page":"102","article-title":"Prevalence of depression and anxiety in people with inflammatory bowel disease and associated healthcare use: population-based cohort study","volume":"24","author":"Irving","year":"2021","journal-title":"BMJ Ment Health"},{"key":"R25-20260402","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1097\/MIB.0000000000000763","article-title":"Demographic and clinical predictors of high healthcare use in patients with inflammatory bowel disease","volume":"22","author":"Click","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"R26-20260402","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/ecco-jcc\/jjy145","article-title":"Depression and health care use in patients with inflammatory bowel disease","volume":"13","author":"Wong","year":"2018","journal-title":"J Crohn's Colitis"},{"key":"R27-20260402","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12876-025-03691-8","article-title":"The relationships between depression, inflammation and self-reported disease activity in IBD and their impact on healthcare usage","volume":"25","author":"Seaton","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"R28-20260402","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4306\/pi.2015.12.1.1","article-title":"Pain and depression: a neurobiological perspective of their relationship","volume":"12","author":"Han","year":"2015","journal-title":"Psychiatry Investig"},{"key":"R29-20260402","first-page":"jjae183","article-title":"Modifiable psychological factors are associated with clusters of pain, fatigue, faecal incontinence and IBS-type symptoms in inflammatory bowel disease: a latent profile analysis","volume":"5","author":"Wileman","year":"2024","journal-title":"J Crohn's Colitis"},{"key":"R30-20260402","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/apt.14493","article-title":"Systematic review: psychosocial factors associated with pain in inflammatory bowel disease","volume":"47","author":"Sweeney","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"R31-20260402","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.crohns.2013.10.005","article-title":"The relationship between coping, health competence and patient participation among patients with inactive inflammatory bowel disease","volume":"8","author":"Gandhi","year":"2014","journal-title":"J Crohn's Colitis"},{"key":"R33-20260402","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cgh.2020.01.030","article-title":"Integrated Psychological Care Reduces Health Care Costs at a Hospital-Based Inflammatory Bowel Disease Service","volume":"19","author":"Lores","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R34-20260402","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.cgh.2020.04.038","article-title":"Cost-effectiveness of telemedicine-directed specialized vs standard care for patients with inflammatory bowel diseases in a randomized trial","volume":"18","author":"de Jong","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R36-20260402","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/flgastro-2019-101260","article-title":"Consensus standards of healthcare for adults and children with inflammatory bowel disease in the UK","volume":"11","author":"Kapasi","year":"2020","journal-title":"Frontline Gastroenterol"},{"key":"R37-20260402","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/wps.21088","article-title":"Therapist-supported Internet-based cognitive behaviour therapy yields similar effects as face-to-face therapy for psychiatric and somatic disorders: an updated systematic review and meta-analysis","volume":"22","author":"Hedman-Lagerl\u00f6f","year":"2023","journal-title":"World Psychiatry"},{"key":"R38-20260402","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S2468-1253(23)00186-3","article-title":"Efficacy of psychological therapies in people with inflammatory bowel disease: a systematic review and meta-analysis","volume":"8","author":"Riggott","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R39-20260402","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1017\/S0033291720002251","article-title":"Online psychological interventions to reduce symptoms of depression, anxiety, and general distress in those with chronic health conditions: A systematic review and meta-analysis of randomized controlled trials","volume":"52","author":"White","year":"2022","journal-title":"Psychol Med"},{"key":"R41-20260402","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/PSY.0000000000001076","article-title":"An evidence-based theory of psychological adjustment to long-term physical health conditions: applications in clinical practice","volume":"84","author":"Carroll","year":"2022","journal-title":"Psychosom Med"},{"key":"R42-20260402","doi-asserted-by":"crossref","first-page":"e053971","DOI":"10.1136\/bmjopen-2021-053971","article-title":"Clinical efficacy of COMPASS, a digital cognitive-behavioural therapy programme for treating anxiety and depression in patients with long-term physical health conditions: a protocol for randomised controlled trial","volume":"11","author":"Hulme","year":"2021","journal-title":"BMJ Open"},{"key":"R43-20260402","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1192\/bjo.2023.519","article-title":"A cognitive\u2013behavioural therapy programme for managing depression and anxiety in long-term physical health conditions: mixed-methods real-world evaluation of the COMPASS programme","volume":"9","author":"Seaton","year":"2023","journal-title":"BJPsych Open"},{"key":"R44-20260402","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/09540261.2011.606803","article-title":"Implementing NICE guidelines for the psychological treatment of depression and anxiety disorders: the IAPT experience","volume":"23","author":"Clark","year":"2011","journal-title":"Int Rev Psychiatry"},{"key":"R45-20260402","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev-clinpsy-050817-084833","article-title":"Realizing the mass public benefit of evidence-based psychological therapies: the IAPT program","volume":"14","author":"Clark","year":"2018","journal-title":"Annu Rev Clin Psychol"},{"key":"R46-20260402","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1017\/S0033291723003756","article-title":"A randomized controlled trial of a digital cognitive-behavioral therapy program (COMPASS) for managing depression and anxiety related to living with a long-term physical health condition","volume":"54","author":"Picariello","year":"2024","journal-title":"Psychol Med"},{"key":"R48-20260402","doi-asserted-by":"crossref","first-page":"107658","DOI":"10.1016\/j.cct.2024.107658","article-title":"A real-world longitudinal study implementing digital screening and treatment for distress in inflammatory bowel disease (IBD): The COMPASS-IBD study protocol","volume":"145","author":"Jones","year":"2024","journal-title":"Contemp Clin Trials"},{"key":"R50-20260402","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/PSY.0000000000000322","article-title":"The patient health questionnaire anxiety and depression scale (PHQ-ADS): Initial validation in three clinical trials","volume":"78","author":"Kroenke","year":"2016","journal-title":"Psychosom Med"},{"key":"R52-20260402","first-page":"77","article-title":"Faecal calprotectin","volume":"39","author":"Pathirana","year":"2018","journal-title":"Clin Biochem Rev"},{"key":"R53-20260402","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1155\/2015\/852723","article-title":"Clinicians\u2019 guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel disease","volume":"29","author":"Bressler","year":"2015","journal-title":"Canadian J Gastroenterol Hepatol"},{"key":"R54-20260402","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.MIB.0000173271.18319.53","article-title":"Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease","volume":"11","author":"Solem","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"R55-20260402","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fmed.2020.00123","article-title":"Serum biomarkers for inflammatory bowel disease","volume":"7","author":"Chen","year":"2020","journal-title":"Front Med"},{"key":"R57-20260402","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/apt.13408","article-title":"Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials","volume":"42","author":"Jairath","year":"2015","journal-title":"Aliment Pharmacol Therap"},{"key":"R58-20260402","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/apt.13001","article-title":"A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity","volume":"41","author":"Khanna","year":"2015","journal-title":"Aliment Pharmacol Therap"},{"key":"R59-20260402","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s41687-025-00851-y","article-title":"A patient-reported outcome measure comprising the stool frequency and abdominal pain items from the Crohn's Disease Activity Index: psychometric evaluation in adults with Crohn's disease","volume":"9","author":"Lewis","year":"2025","journal-title":"J Patient Rep Outcomes"},{"key":"R60-20260402","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","article-title":"European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases","volume":"9","author":"Dignass","year":"2015","journal-title":"J Crohn's Colitis"},{"key":"R61-20260402","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/MPG.0b013e3182128512","article-title":"Role of eosinophils in inflammatory bowel and gastrointestinal diseases","volume":"52","author":"Woodruff","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R62-20260402","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/ecco-jcc\/jjy215","article-title":"Neutrophil extracellular traps sustain inflammatory signals in ulcerative colitis","volume":"13","author":"Dinallo","year":"2019","journal-title":"J Crohn's Colitis"},{"key":"R63-20260402","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/gut.37.3.367","article-title":"Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+ L1+ monocyte derived cells","volume":"37","author":"Rugtveit","year":"1995","journal-title":"Gut"},{"key":"R64-20260402","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.immuni.2015.03.004","article-title":"Distinct commensals induce interleukin-1\u03b2 via NLRP3 inflammasome in inflammatory monocytes to promote intestinal inflammation in response to injury","volume":"42","author":"Seo","year":"2015","journal-title":"Immunity"},{"key":"R65-20260402","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ibd\/izab031","article-title":"Monocytosis is a biomarker of severity in inflammatory bowel disease: analysis of a 6-year Prospective Natural History Registry","volume":"28","author":"Anderson","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"R66-20260402","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2249.2010.04177.x","article-title":"Investigating the role of proinflammatory CD16+ monocytes in the pathogenesis of inflammatory bowel disease","volume":"161","author":"Koch","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"R67-20260402","first-page":"e00429","article-title":"Association between peripheral blood monocyte count and mucosal healing in japanese patients with ulcerative colitis. clinical and translational","volume":"12","author":"Furukawa","year":"2021","journal-title":"Gastroenterology"},{"key":"R68-20260402","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1067\/mob.2003.379","article-title":"Validation of two global impression questionnaires for incontinence","volume":"189","author":"Yalcin","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R69-20260402","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-SD: a measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"key":"R71-20260402","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00042737-200211000-00008","article-title":"Validation of the EuroQol questionnaire in patients with inflammatory bowel disease","volume":"14","author":"K\u00f6nig","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R72-20260402","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1017\/S0033291719001314","article-title":"Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis","volume":"50","author":"Wu","year":"2020","journal-title":"Psychol Med"},{"issue":"1-2","key":"R74-20260402","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.psychres.2010.04.053","article-title":"Accuracy of self-reports of mental health care utilization and calculated costs compared to hospital records","volume":"185","author":"Heinrich","year":"2011","journal-title":"Psychiatry Res"},{"key":"R75-20260402","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hec.1175","article-title":"Comparison of alternative methods of collection of service use data for the economic evaluation of health care interventions","volume":"16","author":"Byford","year":"2007","journal-title":"Health Econ"},{"key":"R76-20260402","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9\u2014validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"R77-20260402","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"R80-20260402","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/eurjcn\/zvae020","article-title":"Hitting the (bio) mark Part 2: analysing, interpreting, and reporting biomarker data in cardiovascular research","volume":"23","author":"Denfeld","year":"2024","journal-title":"Eur J Cardiovasc Nursing"},{"key":"R81-20260402","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1152\/advan.00018.2018","article-title":"Explorations in statistics: the log transformation","volume":"42","author":"Curran-Everett","year":"2018","journal-title":"Adv Physiol Educ"},{"key":"R82-20260402","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MOL.0b013e32832ac03e","article-title":"Human C-reactive protein and the metabolic syndrome","volume":"20","author":"Devaraj","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"R83-20260402","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/01.CIR.0000053731.05365.5A","article-title":"Coming of age of C-reactive protein: using inflammation markers in cardiology","volume":"107","author":"Yeh","year":"2003","journal-title":"Circulation"},{"key":"R84-20260402","doi-asserted-by":"crossref","first-page":"oeab029","DOI":"10.1093\/ehjopen\/oeab029","article-title":"Inflammatory bowel disease and cardiovascular diseases: a concise review","volume":"2","author":"Wu","year":"2022","journal-title":"Eur Heart J Open"},{"key":"R85-20260402","doi-asserted-by":"crossref","first-page":"e074659","DOI":"10.1136\/bmjopen-2023-074659","article-title":"Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"14","author":"Shen","year":"2024","journal-title":"BMJ Open"},{"key":"R86-20260402","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/ibd\/izad175","article-title":"Inflammatory bowel disease is an independent risk factor for metabolic dysfunction\u2013associated steatotic liver disease in lean individuals","volume":"30","author":"Mart\u00ednez-Dom\u00ednguez","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"R87-20260402","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1136\/gutjnl-2024-331914","article-title":"Heavy arch: from inflammatory bowel diseases to metabolic disorders","volume":"73","author":"Adolph","year":"2024","journal-title":"Gut"},{"key":"R88-20260402","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.3390\/ijms22179139","article-title":"Molecular and pathophysiological links between metabolic disorders and inflammatory bowel diseases","volume":"22","author":"Hyun","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R89-20260402","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.amjmed.2022.08.012","article-title":"Inflammatory bowel disease and cardiovascular diseases","volume":"135","author":"Chen","year":"2022","journal-title":"Am J Med"},{"key":"R90-20260402","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1192\/bjp.2018.66","article-title":"Treatment-resistant depression and peripheral C-reactive protein","volume":"214","author":"Chamberlain","year":"2019","journal-title":"Br J Psychiatry"},{"key":"R91-20260402","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/ibd\/izad185","article-title":"Microbial and metabolite signatures of stress reactivity in ulcerative colitis patients in clinical remission predict clinical flare risk","volume":"30","author":"Jacobs","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"R92-20260402","doi-asserted-by":"crossref","first-page":"e11007","DOI":"10.2196\/11007","article-title":"The advantages and disadvantages of online and blended therapy: survey study amongst licensed psychotherapists in Austria","volume":"20","author":"Schuster","year":"2018","journal-title":"J Med Internet Res"},{"key":"R93-20260402","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/apt.16616","article-title":"The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease\u2014results from the Stress, Anxiety and Depression with Disease Activity (SADD) Study","volume":"55","author":"Mules","year":"2022","journal-title":"Aliment Pharmacol Therap"},{"key":"R94-20260402","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MIB.0000000000000341","article-title":"Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission","volume":"21","author":"Falvey","year":"2015","journal-title":"Inflamm Bowel Dis"}],"container-title":["Biopsychosocial Science and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PSY.0000000000001457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:28:40Z","timestamp":1785767320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PSY.0000000000001457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/psy.0000000000001457","relation":{},"ISSN":["2998-8748","2998-8756"],"issn-type":[{"value":"2998-8748","type":"print"},{"value":"2998-8756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"2025-06-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}